Autistic Spectrum Disorders are a complex series of syndromes that have overlapping features. What seems to characterize most of the individual syndromes are: (1.) social disengagement; (2.) language disturbances, including loss of the ability to speak; and (3.) frustration induced aggressive behavior patterns. These syndromes usually begin in early childhood and progress to adulthood. The etiolo
gy of the symptoms is largely unknown to encompass both genetic factors and environmental factors. A variety of management strategies have been offered, including dietary restriction and elimination diets. Recent attention has begun to focus on amino acid therapy. Amino acids can be administered singly or in combination. Certain amino acids are precursors to brain messengers called neurotransmitters. These brain messengers connect one cell to another, a cell to muscle or a nerve cell to a brain cell. These neurotransmitter induced connections form a dense web within both brain structure and neuron brain connections. These neurotransmitter precursors are also concentrated in the cells that surround the nerve and brain cells called glial cells. The various important neurotransmitters include acetylcholine, norepinephrine, dopamine, serotonin and glutamate/glutamine. The neurotransmitter precursors that are used by the brain to produce the neurotransmitters include choline, tyrosine, tryptophan and phenylalanine. Many of the amino acids that produce neurotransmitters are either obligatory or conditionally obligatory amino acids that must be obtained from the diet and are poorly produced by the body itself. Recent advances have led to the ability to use relatively small amounts of neurotransmitter precursors to elicit the formation of neurotransmitters. Moreover, this advanced technology is applied so that the administration of these amino acid precursors do not lose their effectiveness over time. The technology also allows for a reduction in the amount of neurotransmitter precursors that make administration of these agents to children and young adults palatable. These advances make amino acid precursor therapy more practical and more effective. AUT-rms is a formula based on a new advanced technology which allows for the production of specific important neurotransmitters, so that repetitive therapy is both effective and subject to convenient administration for the control of symptoms. AUT-rms is a formula based on a new technology that converts neurotransmitter precursors into neurotransmitters. The neurotransmitters produced include acetylcholine, dopamine, serotonin, glutamate and glutamine. Experience with AUT-rms has shown an 85% reduction in aggressive behavior with two weeks of administration, 70% improvement in language skills within three months and increased socialization with four months. AUT-rms can be used alone or in combination with conventional medications. AUT-rms is based on natural food substances without drugs. As natural food-based substances there are no known allergies or significant side effects. AUT-rms can be administered as capsules or as powders. Powders can be administered in water, juice, or smoothies. AUT-rms can be administered to children, young adults and adult autistic spectrum disorders.
